Treating blood sugar disease with antidepressants: Mirtazapine-based therapy for diabetes (TIIDM): Mirtazapine/Remeron, used in the treatment of depression,anxiety disorders, insomnia, nausea and vomiting, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 28/March/2018, 1.02 pm